CSIMarket



Amgen Inc   (AMGN)
Other Ticker:  
 
 

AMGN's EPS from Cont. Operations Growth by Quarter and Year

Amgen Inc 's EPS from Cont. Operations results by quarter and year




AMGN EPS from Cont. Operations (in $) FY 2022 FY 2021 FY 2020 FY 2019
IV Quarter December - 3.36 2.78 2.88
III Quarter September - 3.32 3.45 3.29
II Quarter June - 0.81 3.07 3.59
I Quarter March 2.69 2.85 3.09 3.20
FY   2.69 10.34 12.39 12.96



AMGN EPS from Cont. Operations first quarter 2022 Y/Y Growth Comment
Amgen Inc reported decrease in EPS from Cont. Operations in the first quarter 2022 by -5.61% to $ 2.69 , from the same quarter in 2021.
The decrease in the first quarter 2022 Amgen Inc 's EPS from Cont. Operations compares unfavorably to the Company's average EPS from Cont. Operations growth of 5.05%.

Looking into first quarter 2022 results within Biotechnology & Pharmaceuticals industry 2 other companies have achieved higher EPS from Cont. Operations growth. While Amgen Inc ' s EPS from Cont. Operations decline of -5.61% ranks overall at the positon no. 283 in the first quarter 2022.




AMGN EPS from Cont. Operations ( Y/Y Growth %) 2022
2021 2020 2019
IV Quarter December - 20.86 % -3.47 % -5.57 %
III Quarter September - -3.77 % 4.86 % 14.24 %
II Quarter June - -73.62 % -14.48 % 2.57 %
I Quarter March -5.61 % -7.77 % -3.44 % -2.14 %
FY   - -16.55 % -4.4 % 2.05 %

Financial Statements
Amgen Inc 's first quarter 2022 EPS from Cont. Operations $ 2.69 AMGN's Income Statement
Amgen Inc 's first quarter 2021 EPS from Cont. Operations $ 2.85 Quarterly AMGN's Income Statement
New: More AMGN's historic EPS from Cont. Operations Growth >>


AMGN EPS from Cont. Operations (Quarter on Quarter Growth %)

2022
2021 2020 2019
IV Quarter December - 1.2 % -19.42 % -12.46 %
III Quarter September - 309.88 % 12.38 % -8.36 %
II Quarter June - -71.58 % -0.65 % 12.19 %
I Quarter March -19.94 % 2.52 % 7.29 % 4.92 %
FY (Year on Year)   - -16.55 % -4.4 % 2.05 %




EPS from Cont. Operations first quarter 2022 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #3
Healthcare Sector #16
Overall #283

EPS from Cont. Operations Y/Y Growth Statistics
High Average Low
236.99 % 5.05 % -76.3 %
(Dec 31 2018)   (Dec 31 2017)
EPS from Cont. Operations first quarter 2022 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #3
Healthcare Sector #16
Overall #283
EPS from Cont. Operations Y/Y Growth Statistics
High Average Low
236.99 % 5.05 % -76.3 %
(Dec 31 2018)   (Dec 31 2017)

EPS from Cont. Operations by Quarter for the Fiscal Years 2019, 2020, 2021, 2022

Amgen Inc 's Q/Q EPS from Cont. Operations Growth


EPS from Cont. Operations Q/Q Growth Statistics
High Average Low
9300 % 142.7 % -98.8 %
(Sep. 30, 2006)  


AMGN's I. Quarter Q/Q EPS from Cont. Operations Comment
In the I. Quarter 2022 Amgen Inc realized fall in EPS from Cont. Operations from the forth quarter by -19.94% to $ 2.69 , from $ 3.36 released a quarter before.

Even cyclical influence which normally energize I. Quarter 2022 results, that clearly could not be enough to rescue AMGN's I. Quarter 2022 outcome, Luke Carter, Biotechnology & Pharmaceuticals industry expert from New York pointed out and wrote that average sequential EPS from Cont. Operations growth is at 142.7% for AMGN.

Within Biotechnology & Pharmaceuticals industry 2 other companies have achieved higher EPS from Cont. Operations quarter on quarter growth. While Amgen Inc 's EPS from Cont. Operations growth quarter on quarter, overall rank is 264.


EPS from Cont. Operations Q/Q Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #3
Healthcare Sector #14
Overall #264
EPS from Cont. Operations Q/Q Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #3
Healthcare Sector #14
Overall #264
EPS from Cont. Operations Q/Q Growth Statistics
High Average Low
9300 % 142.7 % -98.8 %
(Sep. 30, 2006)  


AMGN's I. Quarter Q/Q EPS from Cont. Operations Comment
In the I. Quarter 2022 Amgen Inc reported fall in EPS from Cont. Operations sequentially by -19.94% to $ 2.69 , from $ 3.36 declared in the previous quarter.

Even periodic circumstance which normally energize I. Quarter 2022 results, this clearly was not sufficient to salvage Biotechnology & Pharmaceuticals's company I. Quarter outcome, Luke Carter, Biotechnology & Pharmaceuticals industry expert from New York said and wrote that average sequential EPS from Cont. Operations growth is at 142.7% for AMGN.

Within Biotechnology & Pharmaceuticals industry 2 other companies have achieved higher EPS from Cont. Operations quarter on quarter growth. While Amgen Inc 's EPS from Cont. Operations growth quarter on quarter, overall rank is 264.


Amgen Inc 's 12 Months EPS from Cont. Operations Growth Year on Year


EPS from Cont. Operations TTM Growth

12 Months Ending
(Mar 31 2022)
12 Months Ending
(Dec 31 2021)
12 Months Ending
(Sep 30 2021)
12 Months Ending
(Jun 30 2021)
12 Months Ending
(Mar 31 2021)
Cumulative EPS from Cont. Operations 12 Months Ending $ 10.18 $ 10.34 $ 9.76 $ 9.89 $ 12.15
Y / Y EPS from Cont. Operations Growth (TTM) -16.21 % -16.54 % -21.84 % -19.77 % -5.43 %
Year on Year EPS from Cont. Operations Growth Overall Ranking # 310 # 413 # 1012 # 1478 # 985
Seqeuential EPS from Cont. Operations Change (TTM) -1.55 % 5.95 % -1.31 % -18.6 % -1.94 %
Seq. EPS from Cont. Operations Growth (TTM) Overall Ranking # 283 # 329 # 1350 # 1933 # 1491




Cumulative EPS from Cont. Operations growth Comment
Amgen Inc showed decline, but improvement compare to trailing twelve month EPS from Cont. Operations decrease in Dec 31 2021. If the fiscal year would end in Mar 31 2022, Amgen Inc 's annual EPS from Cont. Operations decline would be -16.21% year on year to $10 .

Among companies within the Healthcare sector 14 other companies have achieved higher trailing twelve month EPS from Cont. Operations growth. While Total ranking has impoved so far to 310, from total ranking in previous quarter at 413.

EPS from Cont. Operations TTM Q/Q Growth Statistics
High Average Low
236.99 %
5.05 %
-76.3 %
 

EPS from Cont. Operations TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 3
Healthcare Sector # 15
Overall # 310

EPS from Cont. Operations TTM Y/Y Growth Statistics
High Average Low
381.31 %
24.26 %
-74.44 %
 


EPS from Cont. Operations TTM Q/Q Growth Company Ranking
Within: No.
Industry # 3
Sector # 16
S&P 500 # 283
Cumulative EPS from Cont. Operations growth Comment
Amgen Inc showed decline, but improvement compare to trailing twelve month EPS from Cont. Operations decrease in Dec 31 2021. If the fiscal year would end in Mar 31 2022, Amgen Inc 's annual EPS from Cont. Operations drop would be -16.21% year on year to $10 .

Among companies within the Healthcare sector 14 other companies have achieved higher trailing twelve month EPS from Cont. Operations growth. While Total ranking has impoved so far to 310, from total ranking in previous quarter at 413.

EPS from Cont. Operations TTM Q/Q Growth Statistics
High Average Low
236.99 %
5.05 %
-76.3 %
 


EPS from Cont. Operations TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 3
Healthcare Sector # 15
Overall # 310

EPS from Cont. Operations TTM Y/Y Growth Statistics
High Average Low
381.31 %
24.26 %
-74.44 %
 


EPS from Cont. Operations TTM Q/Q Growth Company Ranking
Within: No.
Industry # 3
Sector # 16
S&P 500 # 283




Other EPS from Cont. Operations Growth
Biotechnology & Pharmaceuticals Industry EPS from Cont. Operations Growth Trends and Statistics
Healthcare Sector EPS from Cont. Operations Growth Statistics
EPS from Cont. Operations Growth Trends for overall market
AMGN's EPS from Cont. Operations Growth Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking EPS from Cont. Operations Growth
Lowest Ranking EPS from Cont. Operations Growth
EPS from Cont. Operations Growth for AMGN's Competitors
EPS from Cont. Operations Growth for Amgen Inc 's Suppliers
EPS from Cont. Operations Growth for AMGN's Customers

You may also want to know
AMGN's Annual Growth Rates AMGN's Profitability Ratios AMGN's Asset Turnover Ratio AMGN's Dividend Growth
AMGN's Roe AMGN's Valuation Ratios AMGN's Financial Strength Ratios AMGN's Dividend Payout Ratio
AMGN's Roa AMGN's Inventory Turnover Ratio AMGN's Growth Rates AMGN's Dividend Comparisons



Companies with similar EPS from Cont. Operations drop for the quarter ending Mar 31 2022 within Healthcare SectorY/Y Change %EPS from Cont. Operations for the quarter ending Mar 31 2022
Msa Safety Inc-3.23%$ -3.226 
Lemaitre Vascular Inc-3.45%$ -3.448 
Idexx Laboratories Inc-3.77%$ -3.766 
Merit Medical Systems Inc-5.00%$ -5.000 
Addus Homecare Corporation-5.26%$ -5.263 
National Research Corporation-5.56%$ -5.556 
Amgen Inc -5.61%$ -5.614 
Petmed Express Inc-11.44%$ -11.436 
Organon and Co -12.18%$ -12.179 
Regeneron Pharmaceuticals Inc -13.80%$ -13.800 
Natus Medical Inc-14.29%$ -14.286 
Intuitive Surgical Inc -15.24%$ -15.235 
Quest Diagnostics Inc-15.63%$ -15.625 
Universal Health Services Inc -16.67%$ -16.667 
Encompass Health Corporation-18.52%$ -18.519 
Biomx Inc -22.86%$ -22.857 
Davita Inc -22.94%$ -22.936 
Biogen Inc -23.70%$ -23.704 
Hologic Inc-24.58%$ -24.583 
Lifevantage Corp-25.00%$ -25.000 
Integrated Biopharma Inc-25.00%$ -25.000 
Molecular Templates Inc -25.49%$ -25.490 
Fulgent Genetics Inc -26.87%$ -26.868 
Integra Lifesciences Holdings Corp-27.78%$ -27.778 
Reynolds Consumer Products Inc -28.57%$ -28.571 
National Healthcare Corp-28.78%$ -28.777 
Incyte Corp-29.17%$ -29.167 
Semler Scientific inc -31.51%$ -31.507 
Align Technology inc -32.68%$ -32.677 
Laboratory Corporation Of America Holdings-33.12%$ -33.122 


       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

OSI's Profile

Stock Price

OSI's Financials

Business Description

Fundamentals

Charts & Quotes

OSI's News

Suppliers

OSI's Competitors

Customers & Markets

Economic Indicators

OSI's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2022 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071